Infectious Disease Point of Care Diagnostics Market was valued at USD 5.6 Billion in 2022 and is projected to reach USD 11.2 Billion by 2030, growing at a CAGR of 9.1% from 2024 to 2030.
Looking ahead, the market is projected to continue its upward trajectory. Estimates suggest that the global POC diagnostics market could reach USD 80.75 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2033. :contentReference[oaicite:1]{index=1} Specifically, the POC infectious disease testing market is expected to grow from USD 3.2 billion in 2023 to USD 5.9 billion by 2032, reflecting a CAGR of 6.9% during this period. :contentReference[oaicite:2]{index=2} Several factors contribute to this anticipated growth: - **Technological Innovations**: The development of rapid molecular testing and integration with digital platforms has enhanced the accuracy and speed of diagnostics. - **Rising Prevalence of Infectious Diseases**: Emerging pathogens and the resurgence of certain diseases necessitate quick diagnostic solutions. - **Demand for Immediate Results**: Healthcare providers and patients prefer on-the-spot testing to facilitate timely treatment decisions. In my experience, the healthcare industry's shift towards patient-centric care has amplified the demand for POC diagnostics. Clinicians value the ability to make swift decisions based on immediate test results, especially in critical care settings. Patients, too, appreciate the convenience and reduced waiting times associated with POC testing. However, challenges such as pricing pressures due to reimbursement fluctuations may impact market growth. :contentReference[oaicite:3]{index=3} Despite these hurdles, the overall outlook remains positive, with the market poised for substantial expansion in the coming years.
Get an In-Depth Research Analysis of the Global Infectious Disease Point of Care Diagnostics Market Size And Forecast [2025-2032]
The infectious disease point-of-care (POC) diagnostics market has experienced significant growth from 2018 to 2022, driven by technological advancements and the increasing prevalence of infectious diseases. In 2023, the global POC diagnostics market was valued at approximately USD 44.24 billion, with the infectious disease segment accounting for 27.85% of this market. This growth is attributed to the rising cases of diseases such as HIV/AIDS, influenza, and respiratory syncytial virus (RSV). :contentReference[oaicite:0]{index=0}
Â
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Infectious Disease Point of Care Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Infectious Disease Point of Care Diagnostics Market
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Based on Types the Market is categorized into Below types that held the largest Infectious Disease Point of Care Diagnostics market share In 2023.
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Infectious Disease Point of Care Diagnostics Market Research Analysis
1. Introduction of the Global Infectious Disease Point of Care Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Infectious Disease Point of Care Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Infectious Disease Point of Care Diagnostics Market, By Type
6. Global Infectious Disease Point of Care Diagnostics Market, By Application
7. Global Infectious Disease Point of Care Diagnostics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Infectious Disease Point of Care Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/